Muscle & Aging
Does HMB Preserve Muscle During Weight Loss or Bed Rest?
The short answer
The answer splits by setting. During strict bed rest, HMB looked protective: in one trial, healthy older adults confined to bed for 10 days lost 2.05 kg of lean body mass on placebo but only 0.17 kg with HMB, and a meta-analysis of 7 randomized trials found an average 0.35 kg greater muscle-mass gain with HMB versus control in adults 65 and older. During intentional weight loss, the picture reversed: in patients losing weight after bariatric surgery, an HMB-enriched supplement preserved no more fat-free mass than a standard high-protein comparator, and a short-peptide-based formula outperformed the HMB-enriched one at limiting muscle loss. A small trial in boxers cutting weight for competition did find HMB preserved fat-free mass better than placebo over 6 days.
Quick answers
- What is it?
- Whether HMB, a leucine metabolite sold as a supplement, preserves muscle during weight loss or bed rest.
- Why are people interested in it?
- People losing weight or recovering from illness want a supplement that protects their muscle, and HMB is marketed for that purpose.
- What has actually been studied?
- A 10-day bed rest trial and a 7-trial meta-analysis in adults 65 and older, plus trials in bariatric-surgery patients and competitive boxers cutting weight.
- How strong is the evidence?
- It splits by setting — HMB looked genuinely protective during bed rest across small trials, but that protection did not clearly appear during intentional weight loss after bariatric surgery.
- What don't we know yet?
- Whether HMB helps during ordinary, non-surgical calorie-restricted dieting, why the bed-rest benefit didn't clearly replicate in bariatric weight loss, and whether effects differ by age, sex, or starting muscle mass.
- Where can I read the original research?
- Sources at the bottom of this page: Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults: a systematic review and meta-analysis and Effect of β-hydroxy-β-methylbutyrate (HMB) on lean body mass during 10 days of bed rest in older adults.
The short answer: The evidence points two different directions depending on why someone is losing muscle. During enforced physical inactivity — strict bed rest — HMB (beta-hydroxy-beta-methylbutyrate, a metabolite of the amino acid leucine) looked genuinely protective across small trials and a pooled meta-analysis: healthy older adults confined to bed lost far less lean body mass when given HMB than when given placebo. But during intentional weight loss after bariatric surgery, that protective effect did not clearly show up — one trial found no significant difference between an HMB-enriched supplement and a standard high-protein comparator, and another found a short-peptide-based formula preserved more muscle than an HMB-enriched one in the same surgical setting. A small trial of competitive boxers cutting weight found HMB helped there too, muddying any simple "bed rest yes, dieting no" rule. No trial retrieved in this search tested HMB during ordinary, non-surgical calorie restriction in older adults — the setting most people actually mean when they ask this question.
What the research shows
In bed rest, HMB blunted a sharp and rapid muscle loss
The clearest and most consistent finding here concerns bed rest — a well-established model for studying rapid muscle loss from disuse, relevant to hospitalization and recovery from illness or injury. A 2013 randomized, double-blind, placebo-controlled trial in Clinical Nutrition confined 24 healthy older adults (evaluable n=19, ages 60-76) to complete bed rest for 10 days, followed by eight weeks of resistance-training rehabilitation. Participants received either HMB or an inactive placebo powder, starting five days before bed rest and continuing through the end of rehabilitation. In the placebo group, total lean body mass fell by 2.05 kg over the 10 days of bed rest (p=0.02). In the HMB group, the decline was only 0.17 kg (not statistically significant from zero), and the difference between groups was itself significant (p=0.02 by ANOVA). A subgroup analysis restricted to women found the same pattern.
A follow-up study from the same research group, published in the Journal of Applied Physiology in 2017, examined the same 19 participants at the tissue level to understand what HMB might be doing mechanistically. It found HMB was associated with higher markers of mitochondrial content during the eight-week rehabilitation phase and helped maintain certain mitochondrial dynamics proteins, alongside evidence that HMB stimulated intramuscular fat storage as triglyceride during the bed-rest period itself — a set of findings the authors described as suggestive of altered energy metabolism during disuse, though the underlying mechanism for the lean-mass protection was not fully resolved.
These two small trials are consistent with a broader pattern. A 2015 systematic review and meta-analysis in Archives of Gerontology and Geriatrics pooled seven randomized controlled trials comparing HMB against control in adults 65 and older — 147 people on HMB, 140 on control. Averaged across these trials, the HMB groups gained 0.35 kg more muscle mass than control groups (standardized mean difference 0.352 kg; 95% CI 0.11-0.594; p=0.004), with no significant difference in fat mass between groups. The review's authors explicitly flagged bed rest and other forms of disuse as the setting where this effect looked most relevant.
In weight loss after bariatric surgery, the same protection didn't clearly appear
A different pattern emerged in trials set around intentional, surgery-driven weight loss. A 2025 trial in Nutricion Hospitalaria compared two types of protein supplementation in 24 patients in the three months following bariatric surgery — one arm receiving an HMB-supplemented product, the other a standard protein supplement without HMB. Both groups lost substantial weight (17.5 kg vs. 19.1 kg, not a significant difference), but there was no statistically significant difference between groups in muscle mass preserved, fat mass lost, or grip strength (p>0.05 for all). The one significant difference favoring the HMB group was a higher prealbumin level, a general nutritional marker, not a direct measure of muscle.
A separate, larger 2022 trial in Nutrients compared three different post-surgical protein strategies in 60 patients after Roux-en-Y gastric bypass: a standard complex-protein formula, an HMB-enriched formula, and a short-peptide-based formula (designed around evidence that this surgery impairs digestion of complex proteins). One month after surgery, the share of total weight loss that came from fat-free mass was 40.6% in the complex-protein group, 34.57% in the HMB-enriched group, and only 19.14% in the short-peptide group (p<0.001) — meaning the short-peptide formula preserved muscle substantially better than the HMB-enriched formula, even though the short-peptide group lost more total weight (13.56% vs. 9.83% total body weight, p<0.001). In this head-to-head comparison, HMB did not perform as well as an alternative protein strategy.
A partial exception: rapid, short-term weight cutting in athletes
One trial complicates a clean "bed rest yes, dieting no" summary. A 2023 single-blind trial in the Chinese Journal of Physiology studied 12 collegiate boxers during a 6-day acute weight-cutting period before competition, on a matched hypocaloric diet with either HMB or placebo added. Fat-free mass was preserved through the 9-day study period in the HMB group (56.7 kg at baseline, 55.8 kg on day 9) while it fell significantly in the placebo group (55.2 kg to 54.0 kg, p<0.05). Heart-rate response during simulated bouts was also better maintained in the HMB group. This trial involved a much shorter, more extreme weight-cutting protocol in young, elite athletes — a very different population and context from either the bed-rest studies or the bariatric-surgery studies above, which may help explain why its result diverges from the bariatric-surgery findings.
What we don't know yet
Whether HMB helps during ordinary, non-surgical calorie-restricted dieting. Every weight-loss-related trial retrieved here involved either bariatric surgery or an extreme, short-term athletic weight cut. No trial tested HMB during the kind of gradual, sustained calorie restriction most adults use to lose weight.
Why HMB's apparent benefit in bed rest didn't clearly replicate in bariatric-surgery weight loss. Both settings involve rapid muscle loss, yet the trials point in different directions. Whether this reflects the surgery itself, differences in overall protein intake between study arms, or something else about the populations wasn't resolved by the trials retrieved.
Effective dose and duration for weight-loss settings specifically. The positive bed-rest trials used a similar HMB dose (3 g/day) to the negative bariatric trial, so dose alone doesn't obviously explain the divergent results, but no trial systematically varied dose or duration to test this.
Whether effects differ by age, sex, or starting muscle mass. The bed-rest trials were conducted in older adults; the boxing trial in young male athletes; the bariatric trials in a mixed, mostly female surgical population. No retrieved trial compared these populations directly.
Longer-term outcomes. The longest trial retrieved here ran three months. None followed participants long enough to know whether early muscle preservation, where it occurred, persists.
Sources
- Wu H, Xia Y, Jiang J, Du H, Guo X, Liu X, Li C, Huang G, Niu K. Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults: a systematic review and meta-analysis. Archives of Gerontology and Geriatrics, 2015;61(2):168-175. DOI
- Deutz NEP, Pereira SL, Hays NP, Oliver JS, Edens NK, Evans CM, Wolfe RR. Effect of β-hydroxy-β-methylbutyrate (HMB) on lean body mass during 10 days of bed rest in older adults. Clinical Nutrition, 2013;32(5):704-712. DOI
- Standley RA, Distefano G, Pereira SL, Tian M, Kelly OJ, Coen PM, Deutz NEP, Wolfe RR, Goodpaster BH. Effects of β-hydroxy-β-methylbutyrate on skeletal muscle mitochondrial content and dynamics, and lipids after 10 days of bed rest in older adults. Journal of Applied Physiology, 2017;123(5):1092-1100. DOI
- Chang CK, Kao SY, Wang CY. Beta-hydroxy-beta-methylbutyrate supplementation preserves fat-free mass in collegiate boxers during acute body mass loss. The Chinese Journal of Physiology, 2023;66(6):485-493. DOI
- Botella Martínez S, Varo Cenarruzabeitia N, Ribelles Segura MJ, et al. Nutritional impact of beta-hydroxy-β-methylbutyrate supplementation in patients undergoing bariatric surgery. Nutricion Hospitalaria, 2025;43(3):500-508. DOI
- Comas Martínez M, Fidilio Meli E, Palmas Candia F, Cordero E, Hernández I, Vilallonga R, Burgos R, Vila A, Simó R, Ciudin A. Protein Supplementation with Short Peptides Prevents Early Muscle Mass Loss after Roux-en-Y-Gastric Bypass. Nutrients, 2022;14(23):5095. DOI
Article records maintained via PubMed. Peptide Proof reports what studies found. It does not provide medical advice, dosing guidance, or treatment recommendations.
Topic: Energy & Performance · Aging & Longevity
Sources
- Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults: a systematic review and meta-analysis
- Archives of Gerontology and Geriatrics, 2015 · n=287 · DOI
- Effect of β-hydroxy-β-methylbutyrate (HMB) on lean body mass during 10 days of bed rest in older adults
- Clinical Nutrition, 2013 · n=19 · DOI
- Effects of β-hydroxy-β-methylbutyrate on skeletal muscle mitochondrial content and dynamics, and lipids after 10 days of bed rest in older adults
- Journal of Applied Physiology, 2017 · n=19 · DOI
- Beta-hydroxy-beta-methylbutyrate supplementation preserves fat-free mass in collegiate boxers during acute body mass loss
- The Chinese Journal of Physiology, 2023 · n=12 · DOI
- Nutritional impact of beta-hydroxy-β-methylbutyrate supplementation in patients undergoing bariatric surgery
- Nutricion Hospitalaria, 2025 · n=24 · DOI
- Protein Supplementation with Short Peptides Prevents Early Muscle Mass Loss after Roux-en-Y-Gastric Bypass
- Nutrients, 2022 · n=60 · DOI
Get the evidence, not the hype.
New research briefs, plainly written and fully sourced. No dosing advice, ever.